Advertisement

LifeMD, Inc. LFMD

Set alert

Price alert · LFMD

All alert types
2.29 USD -0.03 -1.29%

At close · Oct 30

2.33 +0.04 +1.75%

After hours · Oct 30, 4:36 PM ET

Bid
2.29 × 2
Ask
2.30 × 2
2.24 Day range 2.35
2.08 52-week range 5.91
YTD
-32.84%
1 year
-60.52%
Open
2.30
Prev close
2.32
Mkt cap
110.51M
Vol
599.13K
Avg vol
834.21K
EPS
-0.51
P/E
0.00
Div yield
0.00%
More statistics
Low
2.24
High
2.35
Forward P/E
-124.75
Beta
1.23
Short ratio
7.78
Inst. own
40.48%
Dividend
0.00
Ex-div date
50-d avg
5.34
200-d avg
7.01
1y target
12.00

2Y chart

Chart tools
Interval

Events in this range
  • Nov 7, 2024Earnings: -0.14; estimate -0.1; surprise -40%
  • Nov 11, 2024Rating: HC Wainwright & Co. · Buy → Buy
  • Dec 4, 2024Rating: Mizuho · — → Neutral
  • Dec 10, 2024Rating: Lake Street · — → Buy
Signals (82)
NameDateAgo
MACD: Buy SignalOct 29, 20263 days ago
RSI: OversoldOct 16, 20262 weeks ago
RSI: OversoldOct 12, 20262 weeks ago
MACD: Sell SignalSep 28, 20261 month ago
MACD: Buy SignalAug 19, 20262 months ago
SMA: BearishJul 21, 20263 months ago
SMA: BullishJul 20, 20263 months ago
SMA: BearishJul 17, 20263 months ago
MACD: Sell SignalJul 15, 20263 months ago
SMA: BearishJul 14, 20263 months ago
MACD: Buy SignalJul 6, 20263 months ago
SMA: BullishJul 2, 20264 months ago
SMA: BullishJul 1, 20264 months ago
SMA: BearishJun 25, 20264 months ago
SMA: BullishJun 23, 20264 months ago
SMA: BearishJun 22, 20264 months ago
SMA: BearishJun 22, 20264 months ago
MACD: Sell SignalJun 18, 20264 months ago
MACD: Buy SignalJun 2, 20265 months ago
SMA: BullishJun 1, 20265 months ago
SMA: BearishMay 29, 20265 months ago
SMA: BullishMay 28, 20265 months ago
SMA: BullishMay 26, 20265 months ago
SMA: BearishMay 21, 20265 months ago
MACD: Sell SignalMay 8, 20265 months ago
SMA: BearishMay 7, 20265 months ago
RSI: OverboughtMay 6, 20265 months ago
SMA: BullishMay 4, 20266 months ago
RSI: OverboughtApr 20, 20266 months ago
MACD: Buy SignalApr 16, 20266 months ago
MACD: Sell SignalMar 27, 20267 months ago
RSI: OverboughtMar 16, 20267 months ago
SMA: BullishMar 10, 20267 months ago
RSI: OverboughtMar 10, 20267 months ago
MACD: Buy SignalFeb 26, 20268 months ago
RSI: OversoldFeb 5, 20268 months ago
MACD: Sell SignalJan 21, 20269 months ago
SMA: BearishJan 13, 20269 months ago
SMA: BullishJan 12, 20269 months ago
RSI: OversoldDec 17, 202510 months ago
MACD: Buy SignalDec 4, 202511 months ago
RSI: OversoldNov 10, 202511 months ago
RSI: OversoldNov 4, 202512 months ago
SMA: BearishOct 17, 20251 year ago
MACD: Sell SignalOct 17, 20251 year ago
SMA: BullishOct 15, 20251 year ago
MACD: Buy SignalOct 15, 20251 year ago
MACD: Sell SignalOct 14, 20251 year ago
MACD: Buy SignalAug 26, 20251 year ago
RSI: OversoldAug 19, 20251 year ago
MACD: Sell SignalAug 6, 20251 year ago
RSI: OversoldAug 6, 20251 year ago
SMA: BearishAug 5, 20251 year ago
SMA: BullishAug 4, 20251 year ago
MACD: Buy SignalAug 4, 20251 year ago
SMA: BearishJul 11, 20251 year ago
MACD: Sell SignalJun 25, 20251 year ago
MACD: Buy SignalJun 18, 20251 year ago
RSI: OverboughtJun 16, 20251 year ago
RSI: OverboughtJun 11, 20251 year ago
MACD: Sell SignalJun 6, 20251 year ago
RSI: OverboughtMay 12, 20251 year ago
RSI: OverboughtApr 29, 20251 year ago
SMA: BullishApr 23, 20251 year ago
MACD: Buy SignalApr 17, 20251 year ago
MACD: Sell SignalApr 1, 20251 year ago
SMA: BearishMar 27, 20251 year ago
SMA: BullishMar 24, 20251 year ago
SMA: BearishMar 20, 20251 year ago
SMA: BullishMar 19, 20251 year ago
SMA: BearishMar 18, 20251 year ago
MACD: Buy SignalMar 13, 20251 year ago
SMA: BullishMar 12, 20251 year ago
SMA: BearishFeb 25, 20251 year ago
SMA: BullishFeb 24, 20251 year ago
SMA: BearishFeb 21, 20251 year ago
MACD: Sell SignalFeb 21, 20251 year ago
RSI: OverboughtFeb 13, 20251 year ago
RSI: OverboughtFeb 10, 20251 year ago
MACD: Buy SignalJan 22, 20251 year ago
MACD: Sell SignalJan 10, 20251 year ago
MACD: Buy SignalJan 6, 20251 year ago

Key statistics

Market cap
216.13M
Enterprise value
207.61M
Trailing P/E
0.00
Forward P/E
-124.75
PEG ratio
0.00
Price / sales
1.12
Price / book
0.00
EPS (TTM)
-0.64
Beta
1.23
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-11.66%
Revenue (TTM)
193.06M
Revenue growth
38.30%
Free cash flow
18.01M
Total cash
37.59M
Total debt
25.14M
Return on equity
0.00%
Shares outstanding
43.31M
Short % of float
16.08%
50-day average
5.34
200-day average
7.01

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 12.00 +424.0% upside
Target (low)
7.00
Target (mean)
12.00
Target (high)
16.00
Ratings (0m) 9 8 buy · 1 hold · 0 sell
  • Strong buy1
  • Buy7
  • Hold1
  • Sell0
  • Strong sell0

Next earnings

Consensus EPS estimate 0.14.

Earnings history

Financials — quick view

All financials
LFMD Revenue — quarterly 47.28M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
LFMD Net income — quarterly -7.08M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
LFMD EPS — quarterly -0.16
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

LFMD recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 7, 2024Sep 1, 2024-0.10-0.14-0.04-40.00%
Aug 7, 2024Jun 1, 2024-0.13-0.19-0.06-46.15%
May 8, 2024Mar 1, 2024-0.13-0.19-0.06-46.15%
Mar 11, 2024Dec 1, 2023-0.14-0.12+0.02+14.29%
Nov 8, 2023Sep 1, 2023-0.18-0.20-0.02-11.11%
Aug 9, 2023Jun 1, 2023-0.09-0.23-0.14-155.56%

Upgrades / downgrades

LFMD analyst upgrades and downgrades
DateFirmActionFromTo
Dec 10, 2024Lake Streetinit—Buy
Dec 4, 2024Mizuhoinit—Neutral
Nov 11, 2024HC Wainwright & Co.reitBuyBuy
Sep 20, 2024Cantor FitzgeraldreitOverweightOverweight
Aug 20, 2024Cantor FitzgeraldreitOverweightOverweight
Aug 9, 2024Cantor FitzgeraldreitOverweightOverweight

About LifeMD, Inc.

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies. It also provides LifeMD PC, a direct-to-consumer virtual primary care which includes 24/7 access to a provider for their primary care, urgent care, and chronic care needs; and offers virtual consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, and more. In addition, the company offers PDFSimpli, an online software as a service platform that allows users to create, edit, convert, sign, and share PDF documents; ResumeBuild which provides digital resume and cover letter services; SignSimpli, a digital signature platform; and LegalSimpli, a provider of legal forms for consumers and small businesses. It sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was incorporated in 1994 and is headquartered in New York, New York.

Sector
Healthcare
Industry
Health Information Services
Country
United States
Website
lifemd.com

News

Your note

Sign in to keep a note on LFMD — it syncs with the Stock Master app.

Insider holders

LFMD insider holders
InsiderRelationLatest transactionDateShares held
ALVAREZ NICHOLAS POfficerStock Award(Grant)Mar 20, 2024405,000
DITROLIO JOSEPHDirectorStock Award(Grant)Dec 5, 2024251,048
GALLUPPI STEFANOfficerPurchaseSep 10, 202445,449
JINDAL PIYUSHDirectorStock Award(Grant)Jul 16, 2024362,335
MACRAE CALUM ARCHIBALDDirectorStock Award(Grant)Apr 25, 202416,500
SCHREIBER JUSTINChief Executive OfficerSaleDec 1, 20240

Institution ownership

LFMD institution ownership
Holder% heldSharesValueReported
Blackrock Inc.5.73%2,481,76112.38MSep 29, 2024
Vanguard Group Inc3.93%1,702,5668.50MSep 29, 2024
Divisadero Street Capital Management, LP3.48%1,508,4037.53MSep 29, 2024
State Street Corporation2.67%1,155,4955.77MSep 29, 2024
Royce & Associates LP2.08%901,0414.50MSep 29, 2024
Geode Capital Management, LLC1.89%819,2334.09MSep 29, 2024

Fund ownership

LFMD fund ownership
Holder% heldSharesValueReported
Vanguard Total Stock Market Index Fund2.15%932,5284.65MSep 29, 2024
iShares Russell 2000 ETF2.04%882,9484.41MOct 30, 2024
Royce Small-Cap Opportunity Fund1.20%517,8782.58MSep 29, 2024
SPDR (R) Ser Tr-SPDR� Kensho New Economies Composite ETF1.14%492,7872.46MSep 29, 2024
Vanguard Extended Market Index Fund1.04%449,9452.25MSep 29, 2024
Fidelity Small Cap Index Fund0.83%357,8711.79MAug 30, 2024
Advertisement